Delayed hypersensitivity to antiepileptic drugs in children.

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
Francesca MoriMarina Atanasković-Marković

Abstract

Antiepileptic drugs (AEDs) are widely used for the treatment of epilepsy, but they can be associated with the development of mainly delayed/non-immediate hypersensitivity reactions (HRs). Although these reactions are usually cutaneous, self-limited, and spontaneously resolve within days after drug discontinuation, sometime HR reactions to AEDs can be severe and life-threatening. This paper seeks to show examples on practical management of AED HRs in children starting from a review of what it is already known in literature. Risk factors include age, history of previous AEDs reactions, viral infections, concomitant medications, and genetic factors. The diagnostic workup consists of in vivo (intradermal testing and patch testing) and in vitro tests [serological investigation to exclude the role of viral infection, lymphocyte transformation test (LTT), cytokine detection in ELISpot assays, and granulysin (Grl) in flow cytometry. Treatment is based on a prompt drug discontinuation and mainly on the use of glucocorticoids. Dealing with AED HRs is challenging. The primary goal in the diagnosis and management of HRs to AEDs should be trying to accurately identify the causal trigger and simultaneously identify a safe and effective alter...Continue Reading

References

Jun 1, 1994·The Journal of Investigative Dermatology·J C Roujeau
Nov 1, 1993·Contact Dermatitis·K Alanko
Apr 11, 2000·Epilepsia·J A Messenheimer, A H Guberman
May 2, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J A MessenheimerM E Risner
Aug 18, 2000·Paediatric Drugs·C R Culy, K L Goa
Feb 16, 2002·Contact Dermatitis·A BarbaudUNKNOWN European Society of Contact Dermatitis
May 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hideo HashizumeYoshiki Tokura
Oct 17, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rachel FormanNeil H Shear
Feb 13, 2003·International Journal of Immunopathology and Pharmacology·C FelicianiA Tulli
May 29, 2003·Dermatology : International Journal for Clinical and Investigative Dermatology·S Tas, T Simonart
Feb 17, 2005·International Archives of Allergy and Immunology·Philippe PaquetPascale Quatresooz
Mar 16, 2005·Toxicology·Annick Barbaud
Feb 28, 2006·Epilepsia·Lawrence J HirschStanley R Resor
Oct 5, 2006·Current Pharmaceutical Design·Antonino RomanoJean-Louis Guéant
Mar 28, 2007·Epilepsia·Gaetano ZaccaraEmilio Perucca
May 21, 2008·Epilepsy Research·Silje AlvestadEylert Brodtkorb
Jul 19, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kim B HandokoToine C G Egberts
Nov 11, 2008·Current Pharmaceutical Design·Francesco GaetaAntonino Romano
Aug 4, 2009·European Journal of Drug Metabolism and Pharmacokinetics·Mladena LalicMomir Mikov
Aug 19, 2009·Annales de dermatologie et de vénéréologie·A Barbaud
Oct 9, 2009·Journal of the American Academy of Dermatology·Mark Jean-Aan Koh, Yong-Kwang Tay
Feb 9, 2010·Contact Dermatitis·Felicidade SantiagoAmérico Figueiredo
Oct 5, 2010·Seizure : the Journal of the British Epilepsy Association·Xiang-qing WangFei Yang
Jan 5, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·C Ferrándiz-PulidoV García-Patos
Mar 25, 2011·The New England Journal of Medicine·Mark McCormackMunir Pirmohamed
Sep 16, 2011·Epilepsy Research·Sae-Hoon KimUNKNOWN Adverse Drug Reaction Research Group in Korea
Nov 19, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Y H TangJ C Roujeau
Jan 4, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·Y-T LinW-H Chung
Apr 18, 2012·Archives of Dermatology·Pascal JolyPhilippe Musette
Nov 10, 2012·The British Journal of Dermatology·A BarbaudUNKNOWN Toxidermies group of the French Society of Dermatology
Feb 20, 2013·Pediatrics·Thomas AlexanderMaria Ferris
Apr 17, 2013·Clinical Pharmacology and Therapeutics·U AmstutzUNKNOWN CPNDS Consortium
Jun 12, 2013·Allergy·K SchererUNKNOWN ENDA, the European Network on Drug Allergy and the EAACI Drug Allergy Interest Group
Jul 3, 2013·Joint, Bone, Spine : Revue Du Rhumatisme·Vincent Descamps, Sylvie Ranger-Rogez

❮ Previous
Next ❯

Citations

Apr 2, 2021·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Philippe Eigenmann
May 17, 2021·Current Opinion in Allergy and Clinical Immunology·Marina Atanaskovic-Markovic, Sophia Tsabouri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
Marina Atanasković-MarkovićDejan Škorić
The Journal of Applied Laboratory Medicine
Claire E Knezevic, Mark A Marzinke
The American Journal of Managed Care
Michael Privitera
© 2021 Meta ULC. All rights reserved